Cure My Disease
Don't miss your cure!
Please sign in to follow a disease.
Clinical trials sponsored by Aditya Bagrodia, explained in plain language.
This trial investigates whether Posluma, a PSMA-targeted PET scan, can accurately detect any remaining or returning prostate cancer about 12 months after focal therapy. Researchers will compare the scan results with MRI and biopsy data in 22 men with intermediate-risk, organ-conf…
Phase: PHASE2 • Sponsor: Aditya Bagrodia • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC